Identification | Back Directory | [Name]
LP-261 | [CAS]
915412-67-8 | [Synonyms]
LP-261 N-[3-(1H-indol-4-yl)-5-(2-methoxypyridine-4-carbonyl)phenyl]methanesulfonamide Methanesulfonamide, N-[3-(1H-indol-4-yl)-5-[(2-methoxy-4-pyridinyl)carbonyl]phenyl]- NCI-H522,tubulin polymerization,tumor,SW-620,BXPC-3,H522,anti-mitotic,inhibit,LP261,MCF-7,Inhibitor,Microtubule/Tubulin,LP 261,cancer,Jurkat,LP-261 | [Molecular Formula]
C22H19N3O4S | [MDL Number]
MFCD18782727 | [MOL File]
915412-67-8.mol | [Molecular Weight]
421.47 |
Chemical Properties | Back Directory | [Boiling point ]
700.6±70.0 °C(Predicted) | [density ]
1.391±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
6.72±0.10(Predicted) | [color ]
White to off-white |
|
Company Name: |
NCE Biomedical Co.,Ltd.
|
Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
Website: |
m.is0513.com/ShowSupplierProductsList15748/0.htm |
Company Name: |
SPIRO PHARMA
|
Tel: |
|
Website: |
www.spiropharma.com.cn |
Company Name: |
InvivoChem
|
Tel: |
13549236410 |
Website: |
https://www.invivochem.cn/ |
|